Schuetz M, Schmid MP, Pötter R, Kommata S, Georg D, Lukic D, et al. Evaluating repetitive 18F-fluoroazomycin-arabinoside (18FAZA) PET in the setting of MRI guided adaptive radiotherapy in cervical cancer. AO [Internet]. 2010 Oct. 1 [cited 2024 Nov. 24];49(7):941-7. Available from: https://medicaljournalssweden.se/actaoncologica/article/view/32691